Comparison of Oligon catheters and chlorhexidine-impregnated sponges with standard multilumen central venous catheters for prevention of associated colonization and infections in intensive care unit patients: A multicenter, randomized, controlled study

Critical Care Medicine

Volumn 40, Issue 2, 2012, Pages 420-429

  Arvaniti, Kostoula ^a   Lathyris, Dimitrios ^b   Clouva Molyvdas, Phyllis ^g   Haidich, Anna Bettina ^c   Mouloudi, Eleni ^d   Synnefaki, Eleni ^a   Koulourida, Vasiliki ^a   Georgopoulos, Dimitrios ^e   Gerogianni, Nikoleta ^d   Nakos, Georgios ^f   Matamis, Dimitrios ^a  

^a PAPAGEORGIOU GENERAL HOSPITAL   (Greece)

^b Gennimatas General Hospital   (Greece)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^d Ippokration Hospital Thessaloniki   (Greece)

^e UNIVERSITY HOSPITAL OF IRAKLION   (Greece)

^f UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^g NONE

Author keywords

catheter related infection; central venous catheter; chlorhexidine impregnated sponge; colonization; intensive care; Oligon

Indexed keywords

CHLORHEXIDINE GLUCONATE; SILVER;

ACINETOBACTER BAUMANNII; ADULT; AGED; ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CENTRAL VENOUS CATHETERIZATION; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FEMORAL VEIN; HUMAN; INTENSIVE CARE; INTERNAL JUGULAR VEIN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SUBCLAVIAN VEIN;

ANALYSIS OF VARIANCE; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CHLORHEXIDINE; CRITICAL CARE; CRITICAL ILLNESS; DISINFECTANTS; EQUIPMENT CONTAMINATION; EQUIPMENT DESIGN; FEMALE; GREECE; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; KAPLAN-MEIER ESTIMATE; MALE; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; QUALITY CONTROL; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; STEM CELLS; SURGICAL SPONGES;

EID: 84856203096     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31822f0d4b     Document Type: Article

References (61)

1. Raad II, Bodey GP: Infectious complications of indwelling vascular catheters. Clin Infect Dis 1992; 15:197-208
2. Raad II: Intravascular catheter-related infections. Lancet 1998; 351:893-898
3. Safdar N, Maki DG: The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters. Intensive Care Med 2004; 30:62-67
4. Rijnders BJ, Van Wijngaerden E, Peetermans WE: Catheter-tip colonization as a surrogate end point in clinical studies on catheterrelated bloodstream infection: how strong is the evidence? Clin Infect Dis 2002; 35: 1053-1058
5. Pittet D, Tarara D, Wenzel RP: Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994; 271: 1598-1601
6. Soufir L, Timsit JF, Mahe C, et al: Attributable morbidity and mortality of catheterrelated septicemia in critically ill patients: A matched, risk-adjusted, cohort study. Infect Control Hosp Epidemiol 1999; 20:396-401
7. Rosenthal VD, Guzman S, Migone O, et al: The attributable cost, length of hospital stay, and mortality of central line-associated bloodstream infection in intensive care departments in Argentina: A prospective, matched analysis. Am J Infect Control 2003; 31:475-480
8. Casey AL, Mermel LA, Nightingale P, et al: Antimicrobial central venous catheters in adults: A systematic review and metaanalysis. Lancet Infect Dis 2008; 8:763-776
9. Hu KK, Veenstra DL, Lipsky BA, et al: Use of maximal sterile barriers during central venous catheter insertion: Clinical and economic outcomes. Clin Infect Dis 2004; 39: 1441-1445
10. Chaiyakunapruk N, Veenstra DL, Lipsky BA, et al: Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: A meta-analysis. Ann Intern Med 2002; 136:792-801
11. Warren DK, Zack JE, Cox MJ, et al: An educational intervention to prevent catheterassociated bloodstream infections in a nonteaching, community medical center. Crit Care Med 2003; 31:1959-1963
12. Veenstra DL, Saint S, Sullivan SD: Costeffectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection. JAMA 1999; 282:554-560
13. Darouiche RO, Raad II, Heard SO, et al: A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. N Engl J Med 1999; 340:1-8
14. Crawford AG, Fuhr JP, Rao B: Cost-benefit analysis of chlorhexidine-gluconate dressing in the prevention of catheter-related bloodstream infections. Infect Control Hosp Epidemiol 2004; 25:668-674
15. Timsit JF, Schwebel C, Bouadma L, et al: Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: A randomized controlled trial. Dressing Study Group. JAMA 2009; 301:1231-1241
16. Donelli G, Francolini I: Efficacy of antiadhesive, antibiotic and antiseptic coatings in preventing catheter-related infections: Review. J Chemother 2001; 13:595-606
17. Corral L, Nolla-Salas M, Ibañez-Nolla J, et al: A prospective, randomized study in critically ill patients using the Oligon Vantex catheter. J Hosp Infect 2003; 55:212-219
18. Ranucci M, Isgrò G, Giomarelli PP, et al: Impact of Oligon central venous catheters on catheter colonization and catheter-related bloodstream infection. Crit Care Med 2003; 31:52-59
19. Moretti EW, Ofstead CL, Kristy RM, et al: Impact of central venous catheter type and methods on catheter-related colonization and bacteraemia. J Hosp Infect 2005; 61: 139-145
20. Fraenkel D, Rickard C, Thomas P, et al: A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters. Crit Care Med 2006; 34:668-675
21. Shapiro JM, Bond EL, Garman JK: Use of a chlorhexidine dressing to reduce microbial colonization of epidural catheters. Anesthesiology 1990; 73:625-631
22. Ho KM, Litton E: Use of chlorhexidineimpregnated dressing to prevent vascular and epidural catheter colonization and infection: A meta-analysis. J Antimicrob Chemother 2006; 58:281-287
23. Dima S, Kritsotakis EI, Roumbelaki M, et al: Device-associated nosocomial infection rates in intensive care units in Greece. Infect Control Hosp Epidemiol 2007; 28:602-605
24. Paragioudaki M, Stamouli V, Kolonitsiou F, et al: Intravenous catheter infections associated with bacteraemia: A 2-year study in a university hospital. Clin Microbiol Infect 2004; 10:431-435
25. O'Grady NP, Alexander M, Dellinger EP, et al: Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2002; 35:1281-1307
26. Mermel LA, Farr BM, Sherertz RJ, et al: Infectious Diseases Society of America; American College of Critical Care Medicine; Society for Healthcare Epidemiology of America. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001; 32:1249-1272
27. Timsit JF: Updating of the 12th Consensus Conference of the Societe de Reanimation de langue francaise (SRLF): Catheter related infections in the intensive care unit. Ann Fr Anesth Reanim 2005; 24:315-322
28. Toldos CM, Yague G, Ortiz G, et al: Assessment of multiple coagulase-negative staphylococci isolated in blood cultures using pulsed-field gel electrophoresis. Eur J Clin Microbiol Infect Dis 1997; 16:581-586
29. Knaus WA, Draper EA, Wagner DP, et al: APACHE II, a severity of disease classification system. Crit Care Med 1985; 13:818-829
30. Le Gall JR, Lemeshow S, Saulnier F: A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270:2957-2963
31. Fagon JY, Chastre J, Novara A, et al: Characterization of intensive care unit patients using a model based on the presence or absence of organ dysfunctions and/or infection: The ODIN model. Intensive Care Med 1993; 19: 137-144
32. Vincent JL, de Mendonça A, Cantraine F, et al: Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: Results of a multicenter, prospective study. Working group on 'sepsisrelated problems' of the European Society of Intensive Care Medicine. Crit Care Med 1998; 26:1793-1800
33. Brun-Buisson C, Abrouk F, Legrand P, et al: Diagnosis of central venous catheter related sepsis: Critical level of quantitative tip cultures. Arch Intern Med 1987; 147:873-877
34. Performance Standards for Antimicrobial Susceptibility Testing; 15th Informational Supplement. (Document M100-S15, vol 10). NCCLS Jan 2005
35. Maki DG, Stolz SM, Wheeler S, et al: Prevention of central venous catheter-related bloodstream infection by use of an antisepticimpregnated catheter. A randomized, controlled trial. Ann Intern Med 1997; 127: 257-266
36. Sheng WH, Ko WJ, Wang JT, et al: Evaluation of antiseptic-impregnated central venous catheters for prevention of catheterrelated infection in intensive care unit patients. Diagn Microbiol Infect Dis 2000; 38:1-5
37. Anaissie E: Antimicrobial coating of central venous catheters: Show me the data. Crit Care Med 2007; 35:1197-1199
38. Kalfon P, de Vaumas C, Samba D, et al: Comparison of silver-impregnated with standard multi-lumen central venous catheters in critically ill patients. Crit Care Med 2007; 35:1032-1039
39. Raad I, Darouiche R, Dupuis J, et al: Central venous catheters coated with minocycline and rifampin for the prevention of catheterrelated colonization and bloodstream infections: A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med 1997; 127:267-274
40. O'Grady NP, Chertow DS: Managing bloodstream infections in patients who have short-term central venous catheters. Cleve Clin J Med 2011; 78:10-17
41. Rupp ME, Lisco SJ, Lipsett PA, et al: Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: A randomised controlled trial. Ann Intern Med 2005; 143:570-580
42. Casey AL, Mermel LA, Nightingale P, et al: Antimicrobial central venous catheters in adults: A systematic review and metaanalysis. Lancet Infect Dis 2008; 8:763-776
43. Gilbert RE, Harden M: Effectiveness of impregnated central venous catheters for catheter related blood stream infection: A systematic review. Curr Opin Infect Dis 2008; 21:235-245
44. Ramritu P, Halton K, Collignon P, et al: A systematic review comparing the relative effectiveness of antimicrobial-coated catheters in intensive units. Am J Infect Control 2008; 36:104-117
45. Camins BC, Richmond AM, Dyer KL, et al: A crossover intervention trial evaluating the efficacy of a chlorhexidine-impregnated sponge in reducing catheter-related bloodstream infections among patients undergoing hemodialysis. Infect Control Hosp Epidemiol 2010; 31:1118-1123
46. Merrer J, De Jonghe B, Golliot F, et al: Complications of femoral and subclavian venous catheterization in critically ill patients: A randomized controlled trial. JAMA 2001; 286: 700-707
47. Lorente L, Henry C, Martín MM, et al: Central venous catheter-related infection in a prospective and observational study of 2595 catheters. Crit Care 2005; 9:R631-R635
48. Goetz AM, Wagener MM, Miller JM, et al: Risk of infection due to central venous catheters: Effect of site of placement and catheter type. Infect Control Hosp Epidemiol 1998; 19:842-845
49. Gowardman JR, Robertson IK, Parkes S, et al: Influence of insertion site on central venous catheter colonization and bloodstream infection rates. Intensive Care Med 2008; 34: 1038-1045
50. Lorente L, Jiménez A, Santana M, et al: Microorganisms responsible for intravascular catheter-related bloodstream infection according to the catheter site. Crit Care Med 2007; 35:2424-2427
51. Deshpande KS, Hatem C, Ulrich HL, et al: The incidence of infectious complications of central venous catheters at the subclavian, internal jugular, and femoral sites in an intensive care unit population. Crit Care Med 2005; 33:13-20
52. Gopal Katherason S, Naing L, Jaalam K, et al: Prospective surveillance of nosocomial device-associated bacteremia in three adult intensive units in Malaysia. Trop Biomed 2010; 27:308-316
53. Polderman KH, Girbes AR: Central venous catheter use. Part 2: Infectious complications. Intensive Care Med 2002; 28:18-28
54. Gikas A, Pediaditis J, Papadakis JA, et al: Greek Infection Control Network. Prevalence study of hospital-acquired infections in 14 Greek hospitals: Planning from the local to the national surveillance level. J Hosp Infect 2002; 50:269-275
55. Leblebicioglu H, Rosenthal VD, Arikan OA, et al: Turkish Branch of INICC. Device-associated hospital-acquired infection rates in Turkish intensive care units. Findings of the International Nosocomial Infection Control Consortium (INICC). J Hosp Infect 2007; 65: 251-257
56. Marchaim D, Zaidenstein R, Lazarovitch T, et al: Epidemiology of bacteremia episodes in a single center: Increase in Gram-negative isolates, antibiotics resistance, and patient age. Eur J Clin Microbiol Infect Dis 2008; 27: 1045-1051
57. Doyle JS, Buising KL, Thursky KA, et al: Epidemiology of infections acquired in intensive care units. Semin Respir Crit Care Med 2011; 32:115-138
58. Souli M, Galani I, Giamarellou H: Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe. Euro Surveill 2008; 13:19045
59. Block C, Furman M: Association between intensity of chlorhexidine use and microorganisms of reduced susceptibility in a hospital environment. J Hosp Infect 2002; 51: 201-206
60. Meyer B, Cookson B: Does microbial resistance or adaptation to biocides create a hazard in infection prevention and control? Review. J Hosp Infect 2010; 76:200-205
61. Crnich CJ, Maki DG: Are antimicrobialimpregnated catheters effective? Don't throw out the baby with the bathwater. Clin Infect Dis 2004; 38:1287-1292